Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRobert Walters Regulatory News (RWA)

Share Price Information for Robert Walters (RWA)

Share Price is delayed by 15 minutes
Get Live Data
84.20    1.20 (1.45%)
Bid:
84.40
Ask:
85.00
Spread: 0.60 (0.711%)
Market Cap: £55.39m
RWA Live PriceLast checked at - London Stock Exchange

Intraday Robert Walters Share Chart

Director/PDMR Shareholding

4 Aug 2021 09:06

RNS Number : 5407H
Robert Walters PLC
04 August 2021
 

4 August 2021

ROBERT WALTERS PLC

(the "Company")

Directors' Shareholdings

 

The Company was informed on 3 August 2021 of the following dealings by certain Directors in ordinary shares of 20p each of the Company ("Ordinary Shares") that occurred on the same date.

 

 

Sale of ordinary shares

Robert Walters, Chief Executive Office of the Company, sold 425,000 Ordinary Shares at a price of 660p per share.

 

 

Exercise of share options

Alan Bannatyne, Chief Financial Officer of the Company, exercised options to purchase 190,000 Ordinary Shares at an exercise price of 211p per shares, under the terms of The Robert Walters Executive Share Option Scheme, which were subsequently sold at 660p per share.

 

 

Directors' shareholdings

As a result of the exercise of these share options and subsequent share sales, there has therefore been a change in the overall shareholdings of each of these Directors as set out below:

 

Director

Shareholding prior to this announcement

% holding in Company

Shareholding after this announcement

% holding in Company

Robert Walters

2,660,963

3.48

2,235,963

2.92

Alan Bannatyne

699,283

0.91

699,283

0.91

 

Robert Walters plc's issued share capital consists of 80,432,880 Ordinary Shares with voting rights. Robert Walters plc holds 4,074,000 Ordinary Shares in Treasury.

 

Therefore, the total number of voting rights in Robert Walters plc is 76,358,880.

 

The above figure of 76,358,880 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Robert Walters plc under the FSA's Disclosure and Transparency Rules.

 

 

Enquiries:

Robert Walters plc

Robert Walters, Chief Executive

Alan Bannatyne, Chief Financial Officer +44 20 7379 3333

 

Williams Nicholson

Steffan Williams +44 7767 345 563

 

 

 

 

 

 

APPENDIX

 

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Robert Walters

2.

Reason for the notification

(a)

Position/status

Chief Executive Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Robert Walters plc

(b)

LEI

213800LIE15BDEN3VW43

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary Shares of 20p each

(b)

Identification code of the Financial Instrument

ISIN Code : GB0008475088

(c)

Nature of the transaction

On-market sale of ordinary shares in Robert Walters plc.

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

660p

425,000

(e)

Aggregated information

- Aggregated volume

- Price

 

425,000 (sold) at 660p

 

(f)

Date of the transaction

3 August 2021

(g)

Place of the transaction

London Stock Exchange

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Alan Bannatyne

2.

Reason for the notification

(a)

Position/status

Chief Financial Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Robert Walters plc

(b)

LEI

213800LIE15BDEN3VW43

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary Shares of 20p each

(b)

Identification code of the Financial Instrument

ISIN Code : GB0008475088

(c)

Nature of the transaction

Exercise of option to purchase shares under the terms of Robert Walters Executive Share Option Scheme and the on-market sale of ordinary shares in Robert Walters plc.

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

211p

190,000

660p

190,000

(e)

Aggregated information

- Aggregated volume

- Price

 

190,000 (exercised) at 211p

190,000 (sold) at 660p

 

(f)

Date of the transaction

3 August 2021

(g)

Place of the transaction

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFIFITTSISIIL
Date   Source Headline
1st Oct 20202:30 pmRNSDirectorate Change
17th Sep 20205:19 pmRNSHolding(s) in Company
1st Sep 202012:53 pmRNSTotal Voting Rights
5th Aug 202011:19 amRNSDirectors’ Shareholdings
30th Jul 20207:00 amRNSHalf-yearly financial results
9th Jul 20207:00 amRNSTrading update for Q2 ended 30 June 2020
7th Jul 20207:00 amRNSTR1:Notification
7th Jul 20207:00 amRNSTR1: Notification
30th Jun 202011:00 amRNSTotal Voting Rights
19th May 202012:08 pmRNSSecond Price Monitoring Extn
19th May 202012:02 pmRNSPrice Monitoring Extension
15th May 202012:55 pmRNSHolding(s) in Company
13th May 202012:30 pmRNSResults of 2020 Annual General Meeting
4th May 20208:50 amRNSDirector Declaration
30th Apr 20209:36 amRNSTotal Voting Rights
21st Apr 20204:00 pmRNSDirector/PDMR Shareholding
20th Apr 20207:00 amRNSUpdated AGM Guidance
16th Apr 20207:00 amRNSAnnual Financial Report
14th Apr 20202:27 pmRNSBLOCK LISTING SIX MONTHLY RETURN
9th Apr 20205:44 pmRNSDirector/PDMR Shareholding
8th Apr 20207:00 amRNSTrading update for Q1 ended 31 March 2020
6th Apr 202012:02 pmRNSPrice Monitoring Extension
2nd Apr 20204:37 pmRNSPrice Monitoring Extension
2nd Apr 20207:00 amRNSCOVID-19, Dividend and AGM update
24th Mar 20204:40 pmRNSNotification of major holdings
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:38 pmRNSPrice Monitoring Extension
16th Mar 202012:08 pmRNSSecond Price Monitoring Extn
16th Mar 202012:02 pmRNSPrice Monitoring Extension
11th Mar 20204:40 pmRNSSecond Price Monitoring Extn
11th Mar 20204:35 pmRNSPrice Monitoring Extension
5th Mar 20205:53 pmRNSDirectors' Shareholdings
4th Mar 20204:41 pmRNSSecond Price Monitoring Extn
4th Mar 20204:35 pmRNSPrice Monitoring Extension
4th Mar 20204:24 pmRNSHolding(s) in Company
3rd Mar 202012:29 pmRNSChange of Dividend Record Date
3rd Mar 202012:07 pmRNSSecond Price Monitoring Extn
3rd Mar 202012:02 pmRNSPrice Monitoring Extension
3rd Mar 20207:34 amRNSResults for the year ended 31 December 2019
3rd Mar 20207:00 amRNSRESILIENPERFORMANCE DESPITE GLOBAL TURBULENCE
27th Feb 20209:49 amRNSHolding(s) in Company
27th Feb 20209:47 amRNSHolding(s) in Company
24th Feb 202011:32 amRNSHolding(s) in Company
21st Feb 202012:02 pmRNSPrice Monitoring Extension
31st Jan 20201:59 pmRNSTotal Voting Rights
24th Jan 20204:04 pmRNSNon-executive Director Declaration
9th Jan 20207:00 amRNSTrading Update for Q4 ended 31 December 2019
31st Dec 201910:35 amRNSTotal Voting Rights
29th Nov 201910:41 amRNSTotal Voting Rights
5th Nov 201912:02 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.